News & Updates

A 50,000-IU loading dose of oral vitamin D plus 8,000 IU daily is effective and safe for increasing serum 25(OH)D levels to ≥40 ng/mL in children and adolescents with asthma who were overweight or obese, as opposed to the standard of care (SoC) dose of 600 IU daily, according to findings from the VDORA1* trial.

In the post hoc analysis of data from the phase III LIBERTY ASTHMA VOYAGE study, the monoclonal antibody dupilumab reduced exacerbations and improved lung function in children aged between 6 and 11 years with moderate-to-severe asthma and baseline blood eosinophil count of ≥500 cells/μL.

A large prospective study shows that adults with unhealthy sleep patterns and higher genetic susceptibility have a higher risk of asthma.

A study from Singapore demonstrated the usefulness of a systematic programme using combined microbiologic, serologic, and genomic criteria to assess possible COVID-19 reinfection cases.

Long COVID, sometimes referred to as post-acute sequelae of COVID-19, is still highly prevalent despite improved acute treatments, the emergence of newer variants, and wider vaccination coverage, says an expert at ECCMID 2023.

High-risk outpatients with early-onset COVID-19 who are treated with oral fluvoxamine plus inhaled budesonide have a reduced incidence of severe disease that warrants advanced care, reveals a study.